ABOUT PCG

OUR MISSION

Proton Collaborative Group (PCG) is committed to improving the outcomes of cancer patients by working collectively to advance the role of particle radiotherapy in cancer treatment. PCG serves as the link between state-of-the-art treatment centers, expert physicians, innovative and high-quality collaborative research, and the largest and most comprehensive proton therapy database in the world.

NON-PROFIT
CORPORATION

Originally launched to serve one private company’s treatment centers in 2009, PCG has evolved into an independent 501(c)3 non-profit corporation that currently provides proton therapy-specific clinical research oversight to nine independent treatment centers and institutional members across the US.

OUR RESEARCH

PCG’s partnership with proton treatment centers throughout the country has grown exponentially throughout the years, providing robust data for scientific review. PCG has been represented at several industry conferences, and our research data has been published in the most widely read peer-reviewed journals.

LEARN MORE ABOUT

PROTON
THERAPY

PCG BOARD OF DIRECTORS

     Charles Simone, MD
     President
     New York Proton Center 

     Andrew Chang, MD
     Vice President/Treasurer
     The California Protons Therapy Cancer            Treatment Center

     Dr. Carlos Vargas
     Member at Large
     Mayo Clinic AZ

     Dr. Minesh Mehta
     Member at Large
     Miami Cancer Institute

     George Laramore, PhD, MD
     Secretary
     Seattle Cancer Care Alliance Proton                 Center 

     Dr. Michael Chuong
     Member at Large
     Miami Cancer Institute

PCG STAFF

Jillian Plochocki-Smallwood, MS
Executive Director

Matthew Morocco
Regulatory & Training Manager

Karen Brown
Clinical Research Associate

Edith Maritato
Research Manager

Mary Beth Henry
Data Specialist

WANT TO LEARN MORE?

Contact Proton Collaborative Group (PCG) today and a member of our highly trained staff will reach out to discuss any questions you may have.